Full-Time

Head of Product & Technology

Cara Care

Cara Care

51-200 employees

Digital therapeutics platform for digestive health

No salary listed

Remote in Germany

Remote

Remote within Germany, with regular on-site team events.

Category
Product (2)
,
Required Skills
Product Management
Cybersecurity
Risk Management
REST APIs
DevOps
Data Analysis

Get referred to Cara Care

See people who can refer or advise you

Requirements
  • Senior product and/or technology leadership experience at Head or Vice President level, with ownership of strategy, roadmap, delivery, and team performance.
  • A track record of building consumer-facing or patient-facing digital products with measurable engagement, outcome, and business impact.
  • Technical fluency across modern software architecture, including mobile and web frontend, backend services, application programming interfaces, cloud infrastructure, DevOps, cybersecurity, and data platforms.
  • Experience operating in regulated environments while balancing speed, quality, compliance, privacy, safety, and auditability.
  • People leadership, coaching, hiring, and organizational development skills across Product, Engineering, Design, and Data/AI teams.
  • A pragmatic, hands-on ownership mindset with structured communication and the ability to create clarity in complex environments.
  • Fluency in English.
Responsibilities
  • Set product and technology strategy, roadmap, prioritization, and execution across existing and future digital therapeutic offerings.
  • Own the end-to-end product lifecycle from discovery and delivery through optimization, engagement, and measurable patient impact.
  • Lead engineering architecture across mobile and web frontend, backend services, data, cloud infrastructure, DevOps, security, and integrations.
  • Develop data and artificial intelligence capabilities, including analytics, personalization, automation, experimentation, and responsible artificial-intelligence-enabled product features.
  • Translate clinical, regulatory, reimbursement, privacy, and security requirements into pragmatic product and technology solutions.
  • Establish software-as-a-medical-device lifecycle practices, including risk management, documentation discipline, change control, audit readiness, and post-market considerations.
  • Define the operating model, delivery rhythms, decision rights, and ownership across Product, Engineering, Design, and Data/AI.
  • Lead, hire, coach, and develop a high-performing organization.
  • Manage senior stakeholders across Cara Care, Bayer interfaces, external partners, healthcare ecosystem stakeholders, and relevant infrastructure initiatives.
Desired Qualifications
  • Experience with DiGA, digital therapeutics, software as a medical device, MDR Class I/IIa, ISO/QMS environments, TR-03161, GDPR, or comparable healthcare regulatory frameworks.
  • Familiarity with German healthcare workflows, prescription journeys, healthcare professional interaction, reimbursement logic, Gematik/ePA/eVO, or interoperability standards such as EUDI Wallet.
  • Experience building data-driven and artificial-intelligence-enabled product capabilities such as personalization, recommendations, automation, analytics, or experimentation platforms.
  • Experience working in or with larger enterprise environments while preserving entrepreneurial speed and product focus.
  • German language skills.

Cara Care builds a mobile app that delivers a personalized, multi-therapy program for digestive conditions like IBS, IBD, and GERD. The app combines nutritional therapy, care from certified psychologists, and a digital diary to track symptoms, diet, and well-being, guiding users through individualized plans that adapt over time. In Germany the program is a DiGA prescription medical device reimbursed by statutory health insurances, and the company also offers a US version, supported by investor funding and clinical studies validating its effectiveness. Its goal is to improve access to evidence-based digestive care and support long-term symptom management, while expanding internationally and continuing clinical validation.

Company Size

51-200

Company Stage

Early VC

Total Funding

$17.4M

Headquarters

Berlin, Germany

Founded

2016

Get referred to Cara Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • In March 2026, Germany granted permanent reimbursement for Cara Care IBS.
  • Mahana says Cara Care serves thousands of German patients and tens of thousands worldwide.
  • Mahana's 2024 acquisition funds European expansion into France and the United Kingdom.

What critics are saying

  • Mahana's 2022 layoffs cut roughly half the company, signaling chronic cost pressure.
  • GKV-SV controls German reimbursement pricing; price cuts directly squeeze Cara Care margins.
  • If Mahana deprioritizes digestion, Cara Care becomes an orphaned product inside a larger portfolio.

What makes Cara Care unique

  • Cara Care is Mahana's digestive-health anchor, spanning IBS, IBD, celiac, and heartburn.
  • Its German DiGA status gives prescription access through statutory insurance nationwide.
  • The app combines CBT, nutrition therapy, and symptom tracking in one program.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Paid Vacation

Mental Health Support

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
DigitalFoodLab
Mar 26th, 2024
10 notable deals and things to know this week (2024 - week #13)

Cara Care, a Germany-based startup developing a digital platform to manage digestive health conditions such as IBS, was acquired by Mana Therapeutics, a US-based company.

Mahana Therapeutics
Mar 13th, 2024
Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions | Mahana Therapeutics

‍SAN FRANCISCO, USA – March 12, 2024 – Mahana Therapeutics, a leading provider of digital chronic condition management programs, announced today that it has acquired Berlin-based HiDoc Technologies GmbH, operating as Cara Care, a leader in digital digestive healthcare. This combination creates a global company offering the most comprehensive digestive health portfolio currently addressing Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), Celiac Disease and Heartburn, with an exciting pipeline focused on Tinnitus, Pruritus, and Vulvodynia.

Tech.eu
Mar 12th, 2024
Mahana Therapeutics acquires Berlin's Cara Care, expanding digital treatment for chronic conditions

Mahana Therapeutics acquires Berlin's Cara Care, expanding digital treatment for chronic conditions.

Business Wire
Mar 12th, 2024
Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions

Mahana Therapeutics acquires Cara Care to become a global leader in the digital treatment of chronic conditions.

EU-Startups
Jun 13th, 2022
Berlin-Based Cara Care Lands €6.6 Million For Its Digital Digestive Healthcare App

Digestive health issues are an increasingly common struggle for people across the world. It’s something that many silently suffer and don’t receive adequate care for. Cara Care is on a mission to change this giving everyone access to digestive healthcare via their phones and they’ve just cored €6.6 million.  With a commitment to holistic [] The post Berlin-based Cara Care lands €6.6 million for its digital digestive healthcare app appeared first on EU-Startups.